IP Library Granted Patent US 11,771,774
Granted Patent B2
US 11,771,774 · App. 17/249,006 · Granted Oct 3, 2023

Nerve labeling compositions and uses thereof

Inventors: Jesus Gonzalez (Carlsbad, CA); Junjie Liu (San Diego, CA); Marcel Miampamba (San Diego, CA)
Assignee: Avelas Acquisition Corporation
A61K47/64A61K49/0032A61K49/0043A61K49/0056
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,771,774
App. No.
17/249,006
Granted
Oct 3, 2023
Kind
B2
Abstract

Described herein are methods and compositions for nerve delivery molecules that carry imaging cargo or therapeutic cargo to the neurons or nerves.

Claims (16)

1. A pharmaceutical composition, comprising:

(i) a nerve delivery molecule selected from the group consisting of:

(ii) a pharmaceutically acceptable carrier or excipient.

2. The pharmaceutical composition of claim 1 , wherein the nerve delivery molecule is:

3. The pharmaceutical composition of claim 1 , wherein the nerve delivery molecule is:

4. A method of imaging a target neuron, nerve, or tissue or external structure associated therewith, comprising:

(i) contacting the target neuron, nerve, or tissue or external structure associated therewith with a nerve delivery molecule selected from the group consisting of:

(ii) subsequently imaging the target neuron, nerve, or tissue or external structure associated therewith.

5. The method of claim 4 , wherein the nerve delivery molecule is:

6. The method of claim 4 , wherein the nerve delivery molecule is:

7. A method of imaging a target neuron, nerve, or tissue or external structure associated therewith, comprising:

(i) contacting the target neuron, nerve, or tissue or external structure associated therewith with a pharmaceutical composition comprising a nerve delivery molecule selected from the group consisting of:

a pharmaceutically acceptable carrier or excipient; and

(ii) subsequently imaging the target neuron, nerve, or tissue or external structure associated therewith.

8. The method of claim 7 , wherein the nerve delivery molecule is:

9. The method of claim 7 , wherein the nerve delivery molecule is:

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2023
From: AVELAS BIOSCIENCES, INC.
To: AVELAS (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 063365/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2023
From: AVELAS (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: AVELAS ACQUISITION CORPORATION
Reel/Frame 063365/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2021
From: GONZALEZ, JESUS; LIU, JUNJIE; MIAMPAMBA, MARCEL
To: AVELAS BIOSCIENCES, INC.
Reel/Frame 055297/0950 →
Continuity (4)
Continuation 16466259
Provisional Application 62429617 · Dec 2, 2016
Provisional Application 62429615 · Dec 2, 2016
Related Publication 20210268120A1 · Sep 2, 2021